Sign In

FDA approves next step for QIMR Berghofer-developed immunotherapy

A cellular immunotherapy treatment for multiple sclerosis, which was developed and manufactured at Brisbane’s QIMR Berghofer Medical Research Institute, has been given regulatory approval to enter clinical trials in the US.